Answers are grounded in this paper and cite their sources.
Case report demonstrating improvement in pyogenic granulomas using topical sirolimus treatment.
Pyogenic granulomas (PGs) are benign vascular tumors that present as rapidly growing, friable papules that often bleed and cause cosmetic disfigurement. PGs generally respond well to treatments such as excision, laser, cryotherapy, topical imiquimod, and topical timolol, but agminated PGs can be distressing to patients and challenging to treat. Topical sirolimus, an mTOR inhibitor, is used in the treatment of other vascular anomalies but has not been previously investigated for use in PGs. We report two patients with agminated PGs who demonstrated improvement in size, color, and bleeding following treatment with topical sirolimus.
No takes yet. Share an insight, caveat, or question.
Matre et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: